LY293111 Improves Efficacy of Gemcitabine Therapy on Pancreatic Cancer in a Fluorescent Orthotopic Model in Athymic Mice

LY293111 Improves Efficacy of Gemcitabine Therapy on Pancreatic Cancer in a Fluorescent Orthotopic Model in Athymic Mice

Pancreatic cancer has an abysmal prognosis because of late diagnosis and lack of effective therapeutics. New drugs are desperately needed. The present study determined the effect of the LTB4 receptor antagonist, LY293111, on tumor growth and metastases in a fluorescent orthotopic model of pancreati...

Full description

Bibliographic Details
Main Authors: Rene Hennig, Jacinthe Ventura, Ralf Segersvard, Erin Ward, Xian-Zhong Ding, Sambasiva M. Rao, Borko D. Jovanovic, Takeshi Iwamura, Mark S. Talamonti, Richard H. Bell Jr., Thomas E. Adrian
Format: Article
Language:English
Published: Elsevier 2005-04-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Pancreatic cancer
LY293111
gemcitabine
GFP
orthotopic
tumor model
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558605800739

Similar Items

Similar Items